Patent details

EP3503922 Title: COMBINATION THERAPY FOR THE TREATMENT OF PANCREATIC CANCER

Basic Information

Publication number:
EP3503922
PCT Application Number:
US2017047985
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177614088
PCT Publication Number:
WO2018039211
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY FOR THE TREATMENT OF PANCREATIC CANCER
French Title of Invention:
POLYTHÉRAPIES POUR LE TRAITEMENT DU CANCER DU PANCRÉAS
German Title of Invention:
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS
SPC Number:

Dates

Filing date:
22/08/2017
Grant date:
26/10/2022
EP Publication Date:
03/07/2019
PCT Publication Date:
01/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/10/2022
EP B1 Publication Date:
26/10/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2023
Expiration date:
22/08/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/10/2022
 
 

Name:
Genentech, Inc.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
SETTLEMAN, Jeff
Address:
United States (US)

2

Name:
SAHU, Nisebita
Address:
United States (US)

Priority

Priority Number:
201662378322 P
Priority Date:
23/08/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4523; A61K 31/5025; A61K 31/166; A61K 45/06; A61K 31/18; A61K 31/4184; A61K 31/437; A61K 31/44; A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202243
Publication date:
26/10/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages